Skip to main content
. 2002 Oct 21;87(9):945–949. doi: 10.1038/sj.bjc.6600552

Figure 1.

Figure 1

Overall survival of pontine glioma patients treated with etoposide and trofosfamide (VP16/TRO, n=20), compared to patients with other treatments (controls, n=26). Six patients of the control group were lost to follow up (six censored). The difference between the two groups is not statistically significant (log rank test P=0.7).